Some of our wins include: Abbott Laboratories v Syntron Bioresearch, Inc. In a case involving immunoassay technology, we obtained a jury verdict of patent infringement and a permanent injunction on behalf of Abbott Laboratories. Gates Formed-Fibre Products, Inc. v. Delaware Valley Corp. By persuading a jury that the patents in suit were invalid, we successfully defended our client against accusations of infringement concerning a process for making fused-back automotive carpeting. Comair Rotron, Inc. v Matsushita Electric Corp. of America We obtained a $25 million jury verdict against industry giant Panasonic for willful infringement of our client Comair's patents on fans for electronic equipment. Our successful advocacy extends to patent reexaminations and interferences
Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co. We participated in the representation of Ariad, obtaining a $65 million jury verdict for infringement of our client's patents for regulating NF-kappaB cell-signaling activity, the largest verdict in Massachusetts that year. Comair Rotron v. Nippon Densan Corporation and Nidec Corporation After securing a jury verdict of patent infringement, we negotiated a multimillion dollar settlement for our client Comair Rotron. The patent was directed to important magnetization technology for brushless DC electric motors. B. Braun Medical, Inc. v. NP Medical Inc. and Abbott Laboratories We obtained a jury verdict for Abbott Laboratories and NP Medical, Inc., defeating a $30 million patent infringement claim relating to intravenous valve devices. In disputes over brand names, we have also delivered major successes to our clients.
For our client American Science & Engineering, we obtained a patent that teaches an advanced x-ray technique for improving detection of elusive threats in luggage. Read More |
11 Sunstein lawyers named 2009 Super Stars and Rising Stars. After the Supreme Court's eBay decision (2006), it is harder to win injunctions against patent infringers. As Lisa Tittemore describes in the Federal Lawyer, judges are filling the remedy gap by awarding "ongoing royalties" to patentees, a controversial approach. More. . .
|
• PTO must extend patent terms more generously where its own actions delayed approval of application. More...
|